泰林生物股价跌5.05%，诺安基金旗下1只基金重仓，持有51.12万股浮亏损失86.39万元

Core Insights - TaiLin Bio experienced a decline of 5.05% on September 9, with a stock price of 31.77 CNY per share and a total market capitalization of 3.85 billion CNY [1] Company Overview - TaiLin Bio, established on January 8, 2002, and listed on January 14, 2020, is located in Hangzhou, Zhejiang Province. The company specializes in the research, manufacturing, and sales of microbial detection and control technology systems, as well as organic analysis instruments [1] - The revenue composition of TaiLin Bio includes: 47.03% from sterile production and contamination control equipment, 35.70% from microbial detection technology products, 9.96% from other supplementary products, and 7.32% from organic analysis technology products [1] Shareholder Analysis - The top circulating shareholder of TaiLin Bio includes a fund from NuAn Fund, specifically NuAn Multi-Strategy Mixed A (320016), which entered the top ten circulating shareholders in the second quarter with 511,200 shares, representing 0.67% of circulating shares. The estimated floating loss today is approximately 863,900 CNY [2][4] - NuAn Multi-Strategy Mixed A was established on August 9, 2011, with a latest scale of 1.399 billion CNY. Year-to-date returns are 61.14%, ranking 335 out of 8,179 in its category, while the one-year return is 123.1%, ranking 161 out of 7,984 [2] Fund Manager Performance - The fund managers of NuAn Multi-Strategy Mixed A are Kong Xianzheng and Wang Haichang. Kong has a tenure of 4 years and 288 days, with a total fund asset size of 4.607 billion CNY, achieving a best return of 72.32% and a worst return of -16.74% during his tenure [3] - Wang has a tenure of 3 years and 50 days, managing a total fund asset size of 2.529 billion CNY, with a best return of 60.19% and a worst return of -18.8% during his tenure [3] Fund Holdings - NuAn Multi-Strategy Mixed A increased its holdings in TaiLin Bio by 286,000 shares in the second quarter, bringing its total to 511,200 shares, which constitutes 0.44% of the fund's net value, making it the fourth-largest holding. The estimated floating loss today is approximately 863,900 CNY [4]